PTC THERAPEUTICS, INC. — Director's Dealing 2019

Jan 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2019-01-22

Reporting Person: Boulding Mark Elliott (Exec. VP and CLO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-22	Stock Option (Right to Buy)	$33.02	A	72500	Acquired	2029-01-21	Common Stock (72500)	Direct
2019-01-22	Stock Option (Right to Buy)	$33.02	A	17500	Acquired	2029-01-21	Common Stock (17500)	Direct

Footnotes

F1: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.

F2: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.